Clinical Trial Update: Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating REGEND007 cell therapy for Chronic Obstructive Pulmonary Disease (COPD); the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• REGEND007 Cell Therapy

Snippet

Sponsor: Regend Therapeutics | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | EARLY_Phase 1 | Status: RECRUITING